TR200900880A2 - Pharmaceutical compositions combined in a single dosage form. - Google Patents

Pharmaceutical compositions combined in a single dosage form.

Info

Publication number
TR200900880A2
TR200900880A2 TR2009/00880A TR200900880A TR200900880A2 TR 200900880 A2 TR200900880 A2 TR 200900880A2 TR 2009/00880 A TR2009/00880 A TR 2009/00880A TR 200900880 A TR200900880 A TR 200900880A TR 200900880 A2 TR200900880 A2 TR 200900880A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
dosage form
single dosage
compositions combined
combined
Prior art date
Application number
TR2009/00880A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/00880A priority Critical patent/TR200900880A2/en
Priority to PCT/TR2010/000024 priority patent/WO2010090613A1/en
Publication of TR200900880A2 publication Critical patent/TR200900880A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, aktif maddelerin hastanın tedaviye uyumunu ve dolayısıyla tedavinin başarısını artırmak üzere tek bir dozaj formunda kombine edildiğistabil farmasötik bileşimlere ilişkindir.The present invention relates to stable pharmaceutical compositions in which the active ingredients are combined in a single dosage form to increase patient compliance and hence the success of the treatment.

TR2009/00880A 2009-02-05 2009-02-05 Pharmaceutical compositions combined in a single dosage form. TR200900880A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/00880A TR200900880A2 (en) 2009-02-05 2009-02-05 Pharmaceutical compositions combined in a single dosage form.
PCT/TR2010/000024 WO2010090613A1 (en) 2009-02-05 2010-02-02 The combined pharmaceutical composition in a single dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/00880A TR200900880A2 (en) 2009-02-05 2009-02-05 Pharmaceutical compositions combined in a single dosage form.

Publications (1)

Publication Number Publication Date
TR200900880A2 true TR200900880A2 (en) 2010-08-23

Family

ID=42040315

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/00880A TR200900880A2 (en) 2009-02-05 2009-02-05 Pharmaceutical compositions combined in a single dosage form.

Country Status (2)

Country Link
TR (1) TR200900880A2 (en)
WO (1) WO2010090613A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1019709A3 (en) * 2010-12-22 2012-10-02 Calxx Laboratoires S A ORGANO-MINERAL FOOD PRODUCT AND PROCESS FOR PREPARATION
TR201100153A2 (en) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Effervescent bisphosphonate formulations.
EP4110344A4 (en) * 2020-02-29 2024-03-13 The University Of Vermont USE OF THYROMIMETICS TO TREAT CANCER

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196315B (en) 1984-10-29 1988-11-16 Gentili Ist Spa PROCEDURE FOR THE PREPARATION OF DIPHOSPHONIC ACIDS
AU666313B2 (en) 1991-05-06 1996-02-08 Procter & Gamble Company, The Combined calcium and vitamin D supplements
DE19710054A1 (en) 1997-03-12 1998-09-17 Merck Patent Gmbh Pharmaceutical preparation
ITFI970184A1 (en) 1997-07-30 1999-01-30 Menarini Farma Ind PHARMACEUTICAL COMPOSITIONS CONTAINING VITAMIN D AND CALCIUM, THEIR PREPARATION AND THERAPEUTIC USE
AU2003226148A1 (en) 2002-04-05 2003-10-27 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US7259143B2 (en) 2002-09-05 2007-08-21 Wisconsin Alumni Research Foundation Method of extending the dose range of vitamin D compounds
US20040188316A1 (en) * 2003-03-26 2004-09-30 The Procter & Gamble Company Kit for pharmaceutical use
ITFI20030194A1 (en) 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa PHARMACEUTICAL COMPOSITION EFFERVESCENT CONTAINING
KR20060058134A (en) 2003-09-19 2006-05-29 화이자 프로덕츠 인코포레이티드 Pharmaceutical compositions and methods comprising a combination of 2-alkylidene-19-nor-vitamin di derivatives and bisphosphonates
US20050261250A1 (en) 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
CN1729995A (en) * 2005-08-10 2006-02-08 石家庄制药集团欧意药业有限公司 Pharmaceutical composition for preventing and treating osteoporosis and bone fracture and its application

Also Published As

Publication number Publication date
WO2010090613A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
TR200900878A2 (en) Pharmaceutical formulations combined in a single dosage form
CY1118661T1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCEDURE FOR THEIR PREPARATION, METHODS FOR TREATMENT AND USE OF THESE
TR200900879A2 (en) Pharmaceutical compositions in which the active ingredients are combined in a single dosage form
CY1118813T1 (en) PHARMACEUTICAL COMPOSITIONS OF TRAMADOL AND COXYL-CYLINDERS
IN2012DN06720A (en)
EA201492290A1 (en) COMPOSITIONS AND METHODS FOR VAGINAL DELIVERY OF ANTIPROGHESTINES
MX344238B (en) Tetrazole compounds and methods of making and using same.
HN2011003011A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
MX350046B (en) Treatments for gastrointestinal disorders.
MY161595A (en) Oral care compositions
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
PH12012501620A1 (en) Oral care compositions
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
TR201009394A2 (en) Improved montelukast formulations.
EA201390950A1 (en) HOMOGENEOUS PHARMACEUTICAL ORAL DOSAGE FORMS CONTAINING LERKANIDIPIN AND ENALAPRIL OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS TOGETHER WITH ORGANIC ACID
TR200806300A2 (en) Solubility enhancing pharmaceutical formulation
MX2009008108A (en) Pharmaceutical composition comprising tramadol and ketoprofen.
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
TR201005327A2 (en) Synergistic pharmaceutical formulations.
EA201170950A1 (en) NEW COMBINATION OF ACTIVE INGREDIENTS, CONTAINING Nonsteroid Anti-Inflammatory Drug and Derivative of Colchicoside
TR201100152A2 (en) Effervescent compositions containing amlodipine.
TR200704897A1 (en) Glyclazide formulations providing extended release @
TR200806302A2 (en) Solubility and stability enhancing pharmaceutical formulation.